Allostery Investments LP Cytokinetics Inc Transaction History
Allostery Investments LP
- $95.7 Billion
- Q4 2024
A detailed history of Allostery Investments LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Allostery Investments LP holds 65,000 shares of CYTK stock, worth $3 Million. This represents 3.19% of its overall portfolio holdings.
Number of Shares
65,000Holding current value
$3 Million% of portfolio
3.19%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.24MPut Options Held
2.14M-
Black Rock Inc. New York, NY14.7MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$496 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$364 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$285 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.35B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...